Ueda T, Miyagawa K, Shibata M, Mori Y, et al. Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a retrospective study. BMC Gastroenterol 2026 Jul 4. doi: 10.1186/s12876-026-05075.
PMID: 42399778